Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial. (Q47362291)
Jump to navigation
Jump to search
scientific article published on 13 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial. |
scientific article published on 13 August 2012 |
Statements
1 reference
Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial. (English)
1 reference
Stuart A Ross
1 reference
Elizabeth Rafeiro
1 reference
Thomas Meinicke
1 reference
Robert Toorawa
1 reference
Sonja Weber-Born
1 reference
Hans-Juergen Woerle
1 reference
13 August 2012
1 reference
28
1 reference
1465-1474
1 reference
9
1 reference
Identifiers
1 reference
1 reference